BLADEX, INC. (Banco Latinoamericano de Comercio Exterior, S.A.) — 2012 Form 20-F
Reporting period: Fiscal year ended December 31, 2012; audited consolidated results are presented under U.S. GAAP in U.S. dollars. This is an annual filing, not a standalone fourth-quarter report; the supplied filing text does not provide clear Q4-only financial results.
Business context
Bladex is a Panama-incorporated specialist bank financing Latin American and Caribbean trade, primarily through commercial lending to banks, corporations and middle-market companies. Funding comes mainly from institutional deposits and borrowings. The Asset Management Unit was classified as discontinued operations after the Bank decided in Q4 2012 to divest it.
Financial performance and position
| Metric | 2012 | 2011 |
|---|---|---|
| Net interest income | $105.0 million | $102.7 million |
| Net income attributable to Bladex | $93.0 million | $83.2 million |
| Basic / diluted EPS | $2.46 / $2.45 | $2.25 / $2.24 |
| Net interest margin / spread | 1.70% / 1.44% | 1.81% / 1.62% |
| Return on average assets / equity | 1.51% / 11.57% | 1.46% / 11.40% |
| Total assets | $6.756 billion | $6.360 billion |
| Loans, gross | $5.716 billion | $4.960 billion |
| Total deposits | $2.317 billion | $2.304 billion |
| Borrowings and long-term debt | $1.906 billion | $1.488 billion |
| Stockholders’ equity | $826.5 million | $759.3 million |
- Net interest income rose 2%, as higher loan balances and lending rates were largely offset by increased funding costs. Average funding cost increased to 1.63% from 1.12%; the net interest margin fell 11 basis points.
- Operating expenses increased 11% to $55.8 million, primarily due to higher staffing costs and headquarters-relocation expenses. Management reported an efficiency ratio of 42%, versus 36% in 2011.
- Net cash provided by operating activities was $97.1 million, compared with $180.2 million. Investing activities used $503.8 million, largely reflecting loan growth; financing activities provided $309.8 million. Cash and cash equivalents ended at $692.5 million.
- Management’s liquidity measure was $690 million, down from $786 million; liquid assets were 10.2% of total assets and 29.8% of deposits. The Bank reported that liquid assets covered its $132 million of 24-hour deposits.
- Tier 1 and total capital ratios were 17.9% and 19.2%, respectively, under Basel I; leverage was 8.2 times. Stockholders’ equity was 12.23% of assets.
Material changes versus 2011
- Net income attributable to Bladex rose 12%, principally because of stronger Commercial Division results. Commercial Division net income increased to $96.3 million from $53.4 million; Treasury Division reported an $8.2 million loss, versus $30.2 million income in 2011.
- The commercial portfolio increased 11% to $5.953 billion, while gross loans increased 15%. Growth came especially from corporations and middle-market borrowers; financial-institution exposures declined. About 61% of the commercial portfolio was trade-related, and 76% of loans were scheduled to mature within one year.
- Asset quality improved: year-end non-accrual loans fell to zero from $32 million. The loan-loss allowance declined to $73.0 million from $88.5 million, and allowance coverage of the commercial portfolio declined to 1.31% from 1.83%.
- The Treasury Division’s weaker result reflected higher funding costs, lower average investment-securities balances, lower investment-fund gains, and $5.0 million of amortization after hedge accounting was discontinued for certain instruments. Treasury results also included an $11.2 million trading-securities gain and a $10.5 million foreign-exchange loss.
- Unusual items included a $5.6 million gain on the sale of the former headquarters. The Asset Management Unit reported a $0.7 million discontinued-operations loss; prior-year figures were reclassified to that presentation.
- Available-for-sale securities declined to $183 million from $416 million, following sales and portfolio repositioning. The Bank recorded $6.0 million of net gains on securities sales.
Outlook, risks and contingencies
- Outlook: Management’s stated strategy is to grow selectively in stable, higher-growth regional markets, diversify clients, and develop trade-related products and sector-specific services. The filing provides no quantified earnings or portfolio-growth guidance.
- Asset Management divestiture: On April 2, 2013, the Bank announced a definitive agreement to sell the unit to Alpha4X; completion was expected in Q2 2013. Bladex expected to remain an anchor investor for up to three years. This is a subsequent event, not a completed 2012 transaction.
- Credit and concentration: The loan book is concentrated in Latin America and in a limited number of countries and borrowers. Brazil represented about 31% of loans; Brazil, Peru, Mexico, Colombia and Panama together represented approximately two-thirds. Oil and gas exposure was material within specified corporate, state-exporter and middle-market lending.
- Funding and liquidity: The Bank depends on institutional deposits and international-bank funding; approximately 24% of funding was described as short-term borrowings from international private banks. Five largest depositors represented 48% of deposits. The filing notes there is no traditional central-bank lender of last resort in Panama.
- Other risks: Interest-rate repricing mismatches may pressure net interest income; regional economic, political, currency-control and borrower risks may affect repayment. Competition, market access and funding costs, regulation (including Basel reforms, Dodd-Frank and FATCA), operational systems, fraud and compliance risks are also identified.
- Off-balance-sheet credit exposures were approximately $235 million in the audited notes, principally letters of credit and commitments; the related reserve was $4.8 million. Contractual obligations totaled $5.908 billion, including $1.906 billion of borrowings and long-term debt; some debt covenants could accelerate payment. The Bank said it was in compliance with covenants.
- The filing reports no material litigation and no significant post-year-end change other than disclosed subsequent events. Deloitte issued unqualified opinions on the financial statements and internal control; management concluded disclosure controls and internal control over financial reporting were effective at year-end.
Most important facts for investors to verify
- How much of 2012 earnings growth is repeatable core Commercial Division performance versus credit-reserve reversals, investment/trading results, discontinued operations and the headquarters-sale gain.
- Whether the zero non-accrual balance and lower reserve coverage remain appropriate as the rapidly growing loan portfolio expands; review country, borrower and sector concentrations.
- Funding concentration, short-term maturities, depositor concentration, liquidity availability and the effect of higher borrowing costs on margins.
- Completion and terms of the Asset Management Unit sale, including the anchor-investment commitment and related revenue-sharing arrangements.
- The effect of share issuance and compensation plans on dilution, and the sustainability of the higher quarterly dividend; 2012 regular cash dividends were $1.10 per share.